Neurotrans Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 10

Neurotrans General Information

Description

Manufacturer of vascular interventional and implantable medical devices designed to improve the treatment of cardiovascular, neurovascular, and peripheral vascular conditions. The company offers catheter technologies, vascular stents, functional coatings, energy-based medical device platforms, and physician-engineering collaborative innovation capabilities, enabling healthcare providers and patients to access advanced minimally invasive treatment options with improved clinical outcomes.

Contact Information

Website
neurotrans.com.cn
Formerly Known As
Shanghai Newtek Medical Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 305, Building 4
  • Number 618 Fenghuang Road, Shuangliu District
  • Chengdu, Sichuan 610219
  • China
+86 028
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Vertical(s)
Manufacturing
Corporate Office
  • Room 305, Building 4
  • Number 618 Fenghuang Road, Shuangliu District
  • Chengdu, Sichuan 610219
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotrans Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 20-Jul-2026 Completed Generating Revenue
3. Early Stage VC 30-Apr-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Sep-2023 Completed Generating Revenue
1. Seed Round 13-Oct-2021 Completed Startup
To view Neurotrans’s complete valuation and funding history, request access »

Neurotrans Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BOC International Investment Corporate Venture Capital Minority
Chengdu High-Tech Investment Venture Capital Minority
Chengdu Jiaozi Financial Holding Group Government Minority
Sichuan Venture Capital Venture Capital Minority
Beijing Fengshang Xinhe Investment Fund Management Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Neurotrans FAQs

  • When was Neurotrans founded?

    Neurotrans was founded in 2021.

  • Where is Neurotrans headquartered?

    Neurotrans is headquartered in Chengdu, China.

  • What industry is Neurotrans in?

    Neurotrans’s primary industry is Therapeutic Devices.

  • Is Neurotrans a private or public company?

    Neurotrans is a Private company.

  • What is Neurotrans’s current revenue?

    The current revenue for Neurotrans is .

  • Who are Neurotrans’s investors?

    BOC International Investment, Chengdu High-Tech Investment, Chengdu Jiaozi Financial Holding Group, Sichuan Venture Capital, and Beijing Fengshang Xinhe Investment Fund Management are 5 of 10 investors who have invested in Neurotrans.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process